EISAI INC.

Eisai Inc. experienced an external hacking incident occurring between May 22, 2023, and June 3, 2023. The breach, discovered on August 29, 2023, impacted 13 Maine residents. Compromised data included names along with financial account or credit/debit card numbers and their associated security codes or PINs. The company provided one year of credit monitoring and identity theft protection services to affected individuals.

Eisai Inc. notified consumers of a data breach involving unauthorized access to network files between May 22 and June 3, 2023. The incident exposed names and government identifiers. Eisai engaged forensic investigators, notified law enforcement, and offered credit monitoring services. The investigation was completed by August 29, 2023.

Eisai Inc. notified the New Hampshire Attorney General of a cybersecurity incident involving unauthorized access to network files between May 22 and June 3, 2023. The breach affected 87 New Hampshire residents, whose information (including SSNs and credit card numbers) was accessed. Eisai engaged a cybersecurity firm, notified law enforcement, and began mailing notification letters on October 2, 2023, offering identity protection services.

Eisai Inc reported a data breach to the Montana Attorney General. The breach was reported on 2023-10-02. The breach occurred from 5/22/2023 to 6/3/2023. 6 Montana residents were affected.

Eisai Co., Ltd. is a Japanese multinational pharmaceutical company headquartered in Tokyo. Established in 1941, it's one of the leading firms in the field of neurology and oncology. Eisai produces several drugs used globally such as Aricept for Alzheimer's disease and Halaven for breast cancer. Aside from drug creation, Eisai also engages in global health initiatives.